Market Cap: $37.09B
Market Cap: $37.09B
Open
$19.73
Prev. Close
$19.56
High
$19.74
Low
$19.27
Kenvue Inc. functions as a global leader in the consumer health sector.
Kenvue Inc. trades on the New York Stock Exchange under the ticker KVUE, priced in USD.
Kenvue Inc. has a market capitalisation of $37.09B, based on its latest share price.
KVUE trades at 21.94 times its trailing 12-month earnings.
Over the past 52 weeks KVUE has traded between $15.94 and $20.13.
Yes. Kenvue Inc.'s dividend yields 5.40% at the current share price, paying out 94% of its earnings.
Profitable, with a net margin of 10.9% over the last 12 months.
The analyst consensus rating for KVUE is Hold. Analysts' average 12-month price target of $18.67 implies 3% downside.
Kirk L. Perry is the CEO of Kenvue Inc., which is headquartered in Summit.
Generated automatically from reported financial data. General information only, not financial advice.

Kenvue's Transformation Post-Acquisition Kenvue Inc. ( KVUE ) has recently entered a new chapter following its acquisition by Kimberly-Clark, a strategic move that marks a significant shift in the lan…
Kenvue’s Commitment to Consumer Health Takes Center Stage at Upcoming CAGNY Conference Kenvue Inc., recognized as the world's largest pure-play consumer health company by revenue, prepares to engage w…
Kenvue's Strategic Response to Shareholder Engagement Kenvue Inc., the largest pure-play consumer health company globally by revenue, takes decisive steps in response to shareholder engagement, partic…
Kenvue Sets the Stage for Q4 2024 Financial Results Announcement Kenvue Inc., recognized as the world's largest pure-play consumer health company by revenue, prepares to unveil its fourth quarter and…